These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 13376805)

  • 1. Experimental pyelonephritis. I. Effect of ureteral ligation on the course of bacterial infection in the kidney of the rat.
    BEESON PB; GUZE LB
    J Exp Med; 1956 Dec; 104(6):803-15. PubMed ID: 13376805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on bacteriemia. III. The blood stream clearance of Escherichia coli in rabbits.
    ROGERS DE; MELLY MA
    J Exp Med; 1957 Feb; 105(2):113-24. PubMed ID: 13406172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteremia in the pathogenesis of retrograde E. coli pyelonephritis in the rat.
    Fierer J; Talner L; Braude AI
    Am J Pathol; 1971 Aug; 64(2):443-56. PubMed ID: 4946881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):345-58. PubMed ID: 4590645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary concentrating ability in early experimental pyelonephritis.
    Kaye D; Rocha H
    J Clin Invest; 1970 Jul; 49(7):1427-37. PubMed ID: 4914680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte responses to antigens of gram-negative bacteria in pyelonephritis.
    Wilz SW; Kurnick JT; Pandolfi F; Rubin RH; Warren HS; Goldstein R; Kersten CM; McCluskey RT
    Clin Immunol Immunopathol; 1993 Oct; 69(1):36-42. PubMed ID: 8403542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE FATE OF TUBERCLE BACILLI IN THE ORGANS OF REINFECTED RABBITS.
    Lurie MB
    J Exp Med; 1929 Nov; 50(6):747-65. PubMed ID: 19869661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental pyelonephritis in the monkey. III. Pathophysiology of ureteral malfunction induced by bacteria.
    Roberts JA
    Invest Urol; 1975 Sep; 13(2):117-20. PubMed ID: 810459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat.
    Duymelinck C; Dauwe SE; De Greef KE; Ysebaert DK; Verpooten GA; De Broe ME
    Kidney Int; 2000 Sep; 58(3):1186-201. PubMed ID: 10972681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesangial function in ureteral obstruction in the rat. Blockade of the efferent limb.
    Raij L; Keane WF; Osswald H; Michael A
    J Clin Invest; 1979 Nov; 64(5):1204-12. PubMed ID: 500807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli.
    Matsumoto T; Haraoka M; Mizunoe Y; Takahashi K; Kubo S; Sakumoto M; Tanaka M; Kumazawa J
    Nephron; 1995; 69(1):65-70. PubMed ID: 7891800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired bacterial clearance and trapping in obstructive jaundice.
    Katz S; Grosfeld JL; Gross K; Plager DA; Ross D; Rosenthal RS; Hull M; Weber TR
    Ann Surg; 1984 Jan; 199(1):14-20. PubMed ID: 6362581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental pyelonephritis in dogs.
    Gold AC; Jeffs RD; Wilson RB
    Can J Comp Med; 1968 Apr; 32(2):450-3. PubMed ID: 4233836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin treatment on the susceptibility of the diabetic rat to Escherichia coli-induced pyelonephritis.
    Levison ME; Pitsakis PG
    J Infect Dis; 1984 Oct; 150(4):554-60. PubMed ID: 6386997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical, immunocytochemical and electron microscope studies in experimental E. coli pyelonephritis].
    Iványi B; Krenács T
    Morphol Igazsagugyi Orv Sz; 1989 Apr; 29(2):98-105. PubMed ID: 2664479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of indomethacin on the incidence of experimental Escherichia coli pyelonephritis.
    Glauser MP; Francioli PB; Bille J; Bonard M; Meylan P
    Infect Immun; 1983 May; 40(2):529-33. PubMed ID: 6341240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritis.
    Katsaris MP; Adamis T; Pistiki A; Carrer DP; Galani I; Sabracos L; Droggiti DI; Georgitsi M; Damoraki G; Giamarellos-Bourboulis EJ; Chrisofos M
    J Urol; 2014 Aug; 192(2):600-6. PubMed ID: 24681329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic response of cephalosporin-treated E. coli pyelonephritis of the rat, in relation to variations of the infection model.
    Schulz E; Marre R; Herhahn D; Sack K
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):531-7. PubMed ID: 3901618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and fate of Escherichia coli in hematogenous pyelonephritis.
    SANFORD JP; HUNTER BW; DONALDSON P
    J Exp Med; 1962 Sep; 116(3):285-94. PubMed ID: 14496913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.